As of November 2024 Lineage Cell Therapeutics has a market cap of A$0.26 Billion. This makes Lineage Cell Therapeutics the world's 8146th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 14th, 2024 the market cap of Lineage Cell Therapeutics was reported to be: